Fractyl Health, Inc. Common StockGUTSNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-17.46%
↓ 398% below average
Average (22q)
5.85%
Historical baseline
Range
High:41.88%
Low:-17.46%
Volatility
1013.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -17.46% |
| Q2 2025 | 8.83% |
| Q1 2025 | -4.17% |
| Q4 2024 | 6.72% |
| Q3 2024 | 13.38% |
| Q2 2024 | 16.21% |
| Q1 2024 | 41.88% |
| Q4 2023 | 8.36% |
| Q3 2023 | 2.64% |
| Q2 2023 | -2.22% |
| Q1 2023 | 8.49% |
| Q4 2022 | 0.96% |
| Q3 2022 | -0.77% |
| Q2 2022 | 0.00% |
| Q1 2022 | 10.00% |
| Q4 2021 | 22.71% |
| Q3 2021 | 4.08% |
| Q2 2021 | 0.00% |
| Q1 2021 | -2.39% |
| Q4 2020 | 13.56% |
| Q3 2020 | 3.84% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |